Amicus Therapeutics (NASDAQ:FOLD) Lowered to “Hold” Rating by StockNews.com
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday. A number of other research firms have also recently commented on FOLD. JPMorgan Chase & Co. upped their price objective on shares of Amicus Therapeutics from $16.00 […]
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday. A number of other research firms have also recently commented on FOLD. JPMorgan Chase & Co. upped their price objective on shares of Amicus Therapeutics from $16.00 […]
